carbostyril has been researched along with Edema in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (50.00) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chadha, R; Dureja, J; Jindal, A; Karan, M; Singh, R; Tomar, S | 1 |
| Beekman, JM; Graeber, SY; Hirtz, S; Kruisselbrink, E; Mall, MA; van der Ent, CK; van Mourik, P; Vonk, AM | 1 |
| Alex, AT; Bansal, S; Chaudhary, A; Jaiswal, V; Joesph, A; Lohan, S; Suthar, SK; Tiwari, A | 1 |
| Bae, ON; Chung, JH; Chung, SM; Kim, EJ; Lee, JY; Lee, SM; Lim, KM; Noh, JY | 1 |
| Alam, MM; Alam, MS; Haider, S; Hamid, H; Nazreen, S; Shaharyar, M | 1 |
| Inaba, T; Shishikura, T; Shito, K; Uchida, M | 1 |
| Afantitis, A; Athanasellis, G; Bouloumbasi, D; Detsi, A; Hadjipavlou-Litina, DJ; Igglessi-Markopoulou, O; Kontogiorgis, C; Koufaki, M; Melagraki, G; Prousis, KC | 1 |
| Nourshargh, S; Walsh, DT; Weg, VB; Williams, TJ | 1 |
| Hellewell, PG; Teixeira, MM | 1 |
| Hsu, MF; Kuo, SC; Raung, SL; Wang, JP | 1 |
| Hellewell, PG; Macari, DM; Teixeira, MM | 1 |
| Evans, LA; Norton, KA; Rinaldi, MT; Sutton, SC | 1 |
| Evans, LA; Genereux, PE; Gibbs, EM; Sutton, SC | 1 |
| Owen, K | 1 |
| Inaba, T; Iwamura, H; Kaya, T; Suzuki, H; Ueda, Y | 1 |
| Bobin-Dubigeon, C; Collin, X; Duflos, M; Grimaud, N; Lang, F; Le Baut, G; Petit, JY; Robert, JM; Robin-Dubigeon, C; Wielgosz, G | 1 |
| Tawara, K; Wagai, N | 1 |
| Adachi, O; Ameyama, M; Hamagishi, Y; Kamei, H; Murata, S; Oki, T | 1 |
18 other study(ies) available for carbostyril and Edema
| Article | Year |
|---|---|
Engineering a Remedy to Modulate and Optimize Biopharmaceutical Properties of Rebamipide by Synthesizing New Cocrystal: In Silico and Experimental Studies.
Topics: Alanine; Animals; Biological Availability; Biological Products; Carrageenan; Chemical Engineering; Chemistry, Pharmaceutical; Crystallization; Disease Models, Animal; Drug Compounding; Edema; Humans; Hydrogen Bonding; Indomethacin; Male; Powder Diffraction; Quinolones; Rats; Spectroscopy, Fourier Transform Infrared; Stomach Ulcer | 2021 |
Comparison of Organoid Swelling and
Topics: Adolescent; Adult; Aminophenols; Aminopyridines; Benzodioxoles; Child; Chlorides; Colforsin; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Combinations; Edema; Female; Forced Expiratory Volume; Homozygote; Humans; In Vitro Techniques; Male; Membrane Potentials; Middle Aged; Nasal Mucosa; Organoids; Precision Medicine; Prospective Studies; Quinolones; Rectum; Sweat; Treatment Outcome; Vital Capacity; Young Adult | 2020 |
Novel quinolone substituted thiazolidin-4-ones as anti-inflammatory, anticancer agents: design, synthesis and biological screening.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Carcinoma, Ehrlich Tumor; Carrageenan; Cell Line, Tumor; Cell Survival; Drug Design; Drug Screening Assays, Antitumor; Edema; HeLa Cells; Humans; Inhibitory Concentration 50; Mice; Models, Chemical; Models, Molecular; Molecular Structure; NF-kappa B; Protein Binding; Protein Structure, Tertiary; Quinolones; Rats; Thiazolidines | 2013 |
Potent anti-inflammatory effects of two quinolinedione compounds, OQ1 and OQ21, mediated by dual inhibition of inducible NO synthase and cyclooxygenase-2.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Down-Regulation; Edema; Lipopolysaccharides; Macrophages; Male; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Quinolones; Tetradecanoylphorbol Acetate | 2009 |
Synthesis of novel 8-hydroxy quinolin based 1,3,4-oxadiazoles and S-substituted 1,2,4-triazole derivatives and evaluation of their anti-inflammatory, analgesic, ulcerogenic and anti-microbial activities.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Edema; Gram-Negative Bacteria; Microbial Sensitivity Tests; Molecular Structure; Oxadiazoles; Quinolones; Rats; Rats, Wistar; Stomach Ulcer; Structure-Activity Relationship; Triazoles | 2011 |
A late cutaneous response in actively sensitized rats: a new method for evaluating the efficacy of antiallergic drugs.
Topics: Aminopyridines; Animals; Anti-Allergic Agents; Antigens; Cromolyn Sodium; Cyclosporine; Dinitrobenzenes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Edema; Haptens; Hindlimb; Hypersensitivity, Delayed; Male; ortho-Aminobenzoates; Ovalbumin; Passive Cutaneous Anaphylaxis; Promethazine; Pyridines; Pyrimidinones; Quinolones; Rats; Rats, Wistar | 2006 |
Design and synthesis of novel quinolinone-3-aminoamides and their alpha-lipoic acid adducts as antioxidant and anti-inflammatory agents.
Topics: Amides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biphenyl Compounds; Carrageenan; Dimethyl Sulfoxide; Edema; Female; Hydrazines; Hydroxyl Radical; Lipoxygenase Inhibitors; Male; Oxidation-Reduction; Picrates; Quinolones; Rats; Rats, Inbred F344; Structure-Activity Relationship; Thioctic Acid | 2007 |
Substance P-induced inflammatory responses in guinea-pig skin: the effect of specific NK1 receptor antagonists and the role of endogenous mediators.
Topics: Animals; Antibodies, Monoclonal; Biphenyl Compounds; Chlorpheniramine; Dihydropyridines; Dose-Response Relationship, Drug; Edema; Female; Guinea Pigs; Imidazoles; Indoles; Inflammation; Isoindoles; Neurokinin-1 Receptor Antagonists; Pyrans; Quinolones; Skin; Substance P; Time Factors | 1995 |
Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea-pig.
Topics: Animals; Arachidonic Acid; Edema; Eosinophils; Guinea Pigs; Leukotriene B4; Lipoxygenase Inhibitors; Male; Passive Cutaneous Anaphylaxis; Pyrans; Quinolones | 1994 |
Suppressive effect of 2-phenyl-4-quinolone (YT-1) on hind-paw edema and cutaneous vascular plasma extravasation in mice.
Topics: Animals; Ear Diseases; Edema; Guinea Pigs; Hemorrhage; Hindlimb; Histamine; Ileum; In Vitro Techniques; Leukotriene B4; Mast Cells; Mice; Mice, Inbred ICR; Muscle Contraction; p-Methoxy-N-methylphenethylamine; Quinolones; Rats; Rats, Sprague-Dawley; Serotonin; Skin; Thromboxane B2 | 1994 |
Priming of eosinophil recruitment in vivo by LPS pretreatment.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Azepines; CD18 Antigens; Chemotactic Factors, Eosinophil; Chemotaxis, Leukocyte; Complement C5a, des-Arginine; Cycloheximide; Drug Synergism; Edema; Eosinophilia; Eosinophils; Female; Guinea Pigs; Immunoglobulin G; Interleukin 1 Receptor Antagonist Protein; Leukocyte Count; Leukotriene B4; Lipopolysaccharides; Lipoxygenase Inhibitors; Neutrophils; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Protein Synthesis Inhibitors; Pyrans; Quinolones; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Fusion Proteins; Sialoglycoproteins; Skin; Triazoles; Zymosan | 1996 |
Predicting injection site muscle damage. II: Evaluation of extended release parenteral formulations in animal models.
Topics: Animals; Anti-Infective Agents; Chemistry, Pharmaceutical; Creatine Kinase; Delayed-Action Preparations; Disease Models, Animal; Drug Evaluation, Preclinical; Edema; Evaluation Studies as Topic; Fluoroquinolones; Injections, Intramuscular; Muscles; Predictive Value of Tests; Quinolones; Rabbits; Rats | 1996 |
Predicting injection site muscle damage. III: Evaluation of intramuscular formulations in the L6 cell model.
Topics: Animals; Anti-Infective Agents; Azithromycin; Cells, Cultured; Chemistry, Pharmaceutical; Creatine Kinase; Digoxin; Disease Models, Animal; Drug Evaluation, Preclinical; Edema; Evaluation Studies as Topic; Fluoroquinolones; Injections, Intramuscular; Muscle, Skeletal; Predictive Value of Tests; Quinolones; Rabbits; Rats | 1996 |
Comparative grepafloxacin phototoxicity in mouse skin.
Topics: Alopecia; Animals; Anti-Infective Agents; Dermatitis, Phototoxic; Edema; Erythema; Female; Fluoroquinolones; Mice; Mice, Inbred BALB C; Piperazines; Quinolones; Skin; Ultraviolet Rays | 1998 |
In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoxazines; Camphanes; Carrageenan; Cells, Cultured; CHO Cells; Cricetinae; Cyclic AMP; Dioxoles; Dronabinol; Edema; Genetic Vectors; Hallucinogens; Humans; Indicators and Reagents; Ligands; Mice; Mice, Inbred C57BL; Morpholines; Naphthalenes; Pyrazoles; Quinolones; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Transfection | 2001 |
Synthesis of N-pyridinyl(methyl)-1,2-dihydro-4-hydroxy-2-oxoquinoline-3-carboxamides and analogues and their anti-inflammatory activity in mice and rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Ear, External; Edema; Foot; Male; Mice; Pyridines; Quinolones; Rats; Rats, Wistar; Tetradecanoylphorbol Acetate | 2001 |
Possible reasons for differences in phototoxic potential of a 5 quinolone antibacterial agents: generation of toxic oxygen.
Topics: Animals; Anti-Bacterial Agents; Dimethyl Sulfoxide; Ear, External; Edema; Female; Free Radicals; Hydrogen Peroxide; Mannitol; Mice; Mice, Inbred BALB C; Molecular Structure; Nitroso Compounds; Oxygen; Pentetic Acid; Photochemistry; Quinolones; Superoxides; Ultraviolet Rays | 1992 |
New biological properties of pyrroloquinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema.
Topics: Animals; Brain; Carrageenan; Edema; Lipid Peroxidation; Luminescent Measurements; Male; Mice; Mice, Inbred ICR; N-Formylmethionine Leucyl-Phenylalanine; Peritoneal Cavity; PQQ Cofactor; Quinolones; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Xanthine; Xanthine Oxidase; Xanthines; Zymosan | 1990 |